Metropolis Healthcare Ltd transferred its External Quality Assessment Services Business Division to a wholly owned subsidiary effective August 27, 2026. The transaction was executed as a slump sale for a consideration of ₹1.25 crore.

Metropolis Healthcare completed the transfer of the EQAS Division to Metropolis Quality Solutions Private Limited (MQSPL). The company discharged the consideration by issuing equity shares of MQSPL to itself, in accordance with the terms of the Business Transfer Agreement.

Transaction Details

The transfer was structured as a going concern. Effective August 27, 2026, all operations relating to the EQAS Division are carried out by MQSPL.

Regulatory Disclosure

The company made this disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing follows earlier intimations dated February 4, 2026, and August 4, 2026.

Kamlesh C Kulkarni, Head – Legal & Secretarial, confirmed the transaction in the communication to BSE Limited and National Stock Exchange of India Limited.

Metropolis Healthcare disclosed that its wholly owned subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), has approved the issuance of Optionally Convertible Redeemable Preference Shares (OCRPS). The board authorized the offer on August 20, 2026, as part of a strategic capital structure adjustment for the newly incorporated entity.

The issuance involves 10,000 OCRPS with a face value of ₹10 each, issued at par. The total consideration amounts to ₹1,00,000. Dr. Puneet Kumar Nigam, the former Chief Quality Officer of the company, is the proposed allottee. The disclosure confirmed that Dr. Nigam does not belong to the promoter or promoter group of the listed entity.

Transaction Structure

The OCRPS will convert into equity shares at a ratio of 1:1. This conversion is subject to specific terms and conditions attached to the issuance and will be executed in tranches. The complete conversion process is expected to take up to six years.

Upon successful subscription and subsequent conversion, MQSPL will cease to be a wholly owned subsidiary but will remain a subsidiary of Metropolis Healthcare. The transaction falls outside the scope of a Scheme of Arrangement, and Regulation 37A of the SEBI Listing Regulations is not applicable.

Subsidiary Profile

MQSPL was incorporated on September 15, 2025, under the Indian Companies Act, 2013. As a newly formed entity, it has not yet commenced business operations. Consequently, it contributed no turnover, revenue, income, or net worth to the parent company during the last financial year.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kamlesh Chandrashekhar Kulkarni, Head – Legal & Secretarial, signed the intimation sent to BSE Limited and National Stock Exchange of India Limited.